Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway

NCT06672926 is registered in ClinicalTrials.gov with University Hospitals of North Midlands NHS Trust as lead sponsor.

NCT NCT06672926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway
Lead sponsor
University Hospitals of North Midlands NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
September 23, 2025
Completion date
December 31, 2026
Enrollment
1,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mri, prostate cancer